New heart lead put to the test in 450 patients
NCT ID NCT07342608
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test a new pacing lead called LINEA, designed to be placed in the wall between the heart's lower chambers. Researchers want to see if it is safe and works well in 450 people who need a pacemaker. The main goals are to check for complications and measure how well the lead stimulates the heart after three months.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRADYCARDIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Smarter heart pacing could cut hospital stays for heart failure patients
- Pacemaker tweak may also lower blood pressure
- Could a pacemaker tame stubborn high blood pressure?
- Freezing or burning heart nerves: which works best for slow heartbeat?
- Pacemaker tweak may lower blood pressure in early test
- Could a simple swaddle ease dangerous reflux in preemies?